Jason Drew Smith insider trades: UroGen Pharma (URGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jason reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | URGN | ↓ Sell | 7,479 | $19.69 | $147K | Direct | Feb 11, 2026 (8d) |
| Sep 8, 2025 | URGN | ↓ Sell | 1,520 | $19.11 | $29K | Direct | Sep 9, 2025 (1d) |
| Jul 28, 2025 | URGN | ↓ Sell | 7,522 | $19.14 | $144K | Direct | Jul 30, 2025 (2d) |
| Jan 31, 2025 | URGN | ↓ Sell | 7,379 | $11.14 | $82K | Direct | Feb 4, 2025 (4d) |
| Sep 9, 2024 | URGN | ↓ Sell | 1,521 | $13.08 | $20K | Direct | Sep 12, 2024 (3d) |
| Jan 31, 2024 | URGN | ↓ Sell | 4,993 | $15.74 | $79K | Direct | Feb 2, 2024 (2d) |
| Aug 31, 2023 | URGN | ↓ Sell | 3,800 | $18.01 | $68K | Direct | Sep 5, 2023 (5d) |
| Jan 31, 2023 | URGN | ↓ Sell | 1,636 | $10.12 | $17K | Direct | Feb 2, 2023 (2d) |
| Aug 31, 2022 | URGN | ↓ Sell | 3,606 | $7.21 | $26K | Direct | Sep 2, 2022 (2d) |
| Jan 31, 2022 | URGN | ↓ Sell | 414 | $7.58 | $3K | Direct | Feb 2, 2022 (2d) |
| Nov 30, 2021 | URGN | ↓ Sell | 3,803 | $12.03 | $46K | Direct | Dec 2, 2021 (2d) |
| May 17, 2021 | URGN | ↑ Buy | 2,500 | $15.71 | $39K | Direct | May 18, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other URGN insiders
Open-market trades in the last 12 months
About Jason Drew Smith's insider trades
Jason Drew Smith is General Counsel at UroGen Pharma (URGN). Since May 17, 2021, Jason has reported 1 open-market purchase worth $39K and 11 sales worth $661K on SEC Form 4. In the last 12 months: 1 sale ($147K).
Their filings also include option exercises (11 filings), grants and awards (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every URGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.